In addition, we did not follow up these patients and monitor the dynamical change of serum GP73 levels during the progression of hepatic necroinflammation, though we observed that GP73 expression in liver tissue increased gradually with the severity of hepatic necroinflammation in NASH patients. This evidence concerns the gene GOLM1 and metabolic dysfunction-associated steatohepatitis.